When Joe DeMayo’s donated kidney started to fail earlier than expected, he didn’t know that the drug he was taking could’ve ...

TAC is a potent immunosuppressive agent that is pharmacologically ... TAC is administered orally or by IV infusion. However, because of the risk of anaphylaxis, IV administration of the drug ...

Areas of the body that are more prone to sweating, such as the underarms, groin and the space between the toes, are ...

Other variations of immunosuppressive regimens were subsequently examined, but none had a major impact on clinical transplantation. It was not until the late 1970s with the advent of cyclosporine ...

Regeneron and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent (dupilumab).

In a study published in Circulation Research, the team tested an experimental therapy in animal models based on immunosuppressive nanoparticles and demonstrated that it can slow disease progression.

Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to ...

On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline for diagnosing, monitoring, and treating lupus nephritis (LN), which appeared in Arthritis & Rheumatology.

Outcomes were particularly good with a disease duration of 2 years or shorter. A comparison of immunosuppressive therapies for the treatment of diffuse cutaneous systemic sclerosis found “robust ...

IV therapy for weight loss involves administering vitamins, minerals, or medications directly into your vein. There are no official guidelines for its use in weight loss, and very limited research ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 most profitable NASDAQ stocks to buy now. On June 9, Regeneron ...